Udvalget for Humanmedicinske Lægemidler (CHMP) har konkluderet, at Savene har vist sig effektivt til behandling af ekstravasation af antracykliner og således giver patienterne mulighed for at fortsætte deres kræftbehandling.
The Committee for Medicinal Products for Human Use (CHMP) concluded that Savene had shown its effectiveness in treating anthracycline extravasation, allowing patients to continue their anti-cancer treatment.